ArticleRadiology and oncology2025

Baseline and dynamic changes in skeletal muscle mass as predictive biomarkers in patients with metastatic renal cell carcinoma treated with Nivolumab.

Erdem Ozkan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.